ArticleCVIR endovascular2026
Endovascular treatment of true visceral artery aneurysms: a decade of experience and key outcomes from a high-volume single center.
Article in CVIR endovascular, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Human-AI Interaction in Interventional Radiology: A Narrative Review of Current Applications, Challenges, and Future Directions.Journal of imaging · 2026Review
- Endovascular Treatment for a Huge Celiac Artery Aneurysm: 13-Year Follow-Up.Annals of vascular diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndovascular approach has emerged as the first-choice treatment of visceral artery aneurysms (VAAs). However, most published series include heterogeneous populations combining true aneurysms and pseudoaneurysms. Our single-center retrospective study aimed to evaluate a large and homogenous series of true VAAs treated endovascularly. Demographic, clinical and procedural details of patients with VAAs treated at our Interventional Radiology unit from January 2014 to January 2025 were collected in a dedicated database. Intraprocedural and perioperative outcomes included technical success, complications, mortality and need for reintervention. At long-term follow-up, overall survival, aneurysm-related complications, freedom from reintervention, and aneurysmal sac reperfusion were evaluated.
resultsNinety-four consecutive patients (41 men; median age: 67.3 years; range 29-98 years) with 97 VAAs were included in the study. VAAs had a median diameter of 2.93 cm (range 6-9.2 cm). Treatment strategies included sac packing in 45 VAAs, sandwich technique in 35, covered stent placement in 13, afferent artery occlusion in 5 and stent-assisted coiling in 4 cases. Technical success rate was 100% with no perioperative deaths. Perioperative major complication and reintervention rates were 5.2% and 2.1%, respectively. At a mean follow-up of 44.7 ± 28.9 months, overall survival, freedom from aneurysm-related complications, and freedom from reintervention were 89.4%, 92.8%, and 93.8%, respectively. Aneurysm sac reperfusion was observed in 8(8.2%) cases. No aneurysm-related deaths occurred.
conclusionEndovascular approach is a safe and effective first-line option in patients with true VAAs, with notable results in terms of complication and freedom from reintervention rates and an excellent long-term overall survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.